Subtherapeutic Linezolid Concentration in a Patient With Bullous Pemphigoid Complicated by Methicillin-Resistant Staphylococcus aureus Infection: A Case Study

Congqin Chen; Min Zhang; Hong Chen; Jie Fang

doi:10.1097/FTD.0000000000000758

Subtherapeutic Linezolid Concentration in a Patient With Bullous Pemphigoid Complicated by Methicillin-Resistant Staphylococcus aureus Infection: A Case Study

Ther Drug Monit. 2020 Aug;42(4):515-517. doi: 10.1097/FTD.0000000000000758.

Authors

Congqin Chen¹, Min Zhang², Hong Chen^{3

4}, Jie Fang⁵

Affiliations

¹ Department of Pharmacy, Xiamen Cardiovascular Hospital, Xiamen University, Xiamen, Fujian, China.
² Department of Pharmacy Services, Boston Medical Center, Boston, Massachusetts.
³ Department of Respiration and Critical Care Disease, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
⁴ Institute of Respiratory Diseases, School of Medicine, Shanghai Jiaotong University, Shanghai, China; and.
⁵ Department of Pharmacy, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.

PMID: 32217880
DOI: 10.1097/FTD.0000000000000758

Abstract

We presented a case of subtherapeutic linezolid concentration in a patient with bullous pemphigoid characterized by large area skin anabrosis complicated by methicillin-resistant Staphylococcus aureus infections.

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Anti-Bacterial Agents / administration & dosage*
Humans
Linezolid / administration & dosage*
Male
Methicillin-Resistant Staphylococcus aureus / drug effects*
Pemphigoid, Bullous / drug therapy*
Pemphigoid, Bullous / microbiology*
Staphylococcal Infections / drug therapy*
Staphylococcal Infections / microbiology

Substances

Anti-Bacterial Agents
Linezolid